retatrutide sleep apnea A Study of (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1) Lilly's Investigational Triple Agonist Retatrutide

Patients reported that clinicians offered banal advice assuming that the patients were unhealthy or were not trying to address their weight, and assumed that other health symptoms were due to obesity without a proper medical history or examination [14]

Who can benefit: Adults struggling with obesity, metabolic syndrome, or stubborn weight despite diet and exerciseespecially those who want a safe, supervised plan that focuses on long-term health, not just quick fixes

Istanbul Med Assist ensures a comfortable and efficient healthcare experience for all

For instance, tirzepatide recently gained approval for treating moderate to severe obstructive sleep apnea in adults with obesity